Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with severe brain injuries, such as ischemic stroke and intracranial hemorrhage, frequently require mechanical ventilation. Weaning of stroke patients is complicated by impaired consciousness and respiratory drive. Higher rates of weaning failure and delayed extubation (≥ 48h) lead to ventilator associated pneumonia, higher mortality and necessity of tracheostomy.
Therefore, improving the weaning of stroke patients from mechanical ventilation is warranted to prevent ventilator-associated complications and eventually improve clinical outcomes.
This single-center, randomized, clinical trial aims at demonstrating that voices of patients' relatives support weaning from mechanical ventilation and reduce weaning failure in brain-injured patients.
Methods: Adult ICU-patients with controlled mechanical ventilation ≥48h due to a neurological disease will be included in the intensive care unit. A predefined text - including information on the patient's condition and recurrent request to breath in and out - will be recorded as an audio file by one of the patient's relatives. Patients will be randomly assigned in a 1:1 ratio to the conventional treatment arm or the Voice-Weaning arm. In the conventional arm, audio recordings will be muted by an independent person resulting in a mute recording without audio signals.
When conversion from controlled to assisted mechanical ventilation is intended according to standard treatment, audio recordings will be administered in repeat mode for 10 minutes and performed three times per day. If spontaneous breathing trials (SBT) are intended according to standard treatment, the audio recordings will be played during the SBT three times per day.
Criteria for weaning not to be intended - according to Boles et al. (Weaning from mechanical ventilation. Eur Respir J. 2007) and adapted to neurological patients:
Objective measurements:
Unstable clinical condition
Inadequate oxygenation
Inadequate pulmonary function
Unstable neurological condition
Clinical assessment:
Ethics Approval: The Institutional Review Board of the Friedrich-Alexander-Universität Erlangen-Nürnberg approved of the study on 13 November 2018.
Sample Size Calculation: The sample size is computed with 80% power and a 5% α-risk for the hypothesis of Voice Weaning achieving a 15% absolute weaning failure reduction. The sample size is increased by 10% to correct for dropouts and lost to follow up: a maximum of 354 patients will be included and an interim analysis be performed after inclusion of 50% of the calculated subjects.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Conventional arm | Sham Comparator | Muted audio recordings of the patients relatives. |
|
| Voice-Weaning arm | Experimental | Audio recordings of the patients relatives including information on the patient's condition and recurrent request to breath in and out. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Voice-Weaning | Other | Audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of weaning failure | Reintubation and/or resumption of ventilatory support following extubation or death following extubation or failed spontaneous breathing trial | first 28 days after start of ventilation, or until 48 hours after extubation, or discharge from intensive care, whichever came first |
| Measure | Description | Time Frame |
|---|---|---|
| Time of controlled ventilation | first 28 days after start of ventilation or discharge from intensive care, whichever came first | |
| Rate of tracheotomy | Proportion of patients requiring tracheotomy performed as percutaneous dilatative tracheotomy or surgical tracheotomy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hagen B. Huttner, MD, PhD | University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany | Principal Investigator |
| Joji B. Kuramatsu, MD | University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany | Principal Investigator |
| Maximilian I. Sprügel, MD | University of Erlangen-Nürnberg Medical School, Department of Neurology, Germany | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Giessen | Giessen | Germany |
Because of local ethics committees restrictions the final decision upon release of the raw data has not been made.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001930 | Brain Injuries |
| D016638 | Critical Illness |
| D012120 | Respiration Disorders |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sham control | Other | Muted audio recordings of patients' relatives for 10 minutes x 3 daily from initiation of assisted mechanical ventilation to extubation or ICU discharge. |
|
| first 28 days after start of ventilation or discharge from intensive care, whichever came first |
| All cause mortality rate at 90 days | first 90 days after start of ventilation |
| Rate of ICU delirium | Development of delirium according to the Confusion Assessment Method for intensive care unit (CAM-ICU) | first 28 days after start of ventilation or discharge from intensive care, whichever came first |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012140 | Respiratory Tract Diseases |